News
June 18, 2012 — Endosense announced its TactiCath Quartz force-sensing ablation catheter has been CE mark approved for use in Europe. In cooperation with the company’s distributor Biotronik, first cases using the new device have been performed by renowned physicians at three centers across Europe.
June 18, 2012
News
June 18, 2012 — United Health Services (UHS), a locally owned, not-for-profit, 916-bed hospital and healthcare system serving the greater Binghamton, N.Y. area has selected Philips Live 3-D transesophageal echo (TEE) technology for cardiac care, marking the system’s 2,500th installation in North America.
June 18, 2012News
June 15, 2012 — Boston Scientific Corp. has initiated use of the LATITUDE NXT Remote Patient Management System with patients in Europe.
June 15, 2012Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
June 15, 2012 —Vascular Solutions Inc. today announced that it has acquired the radial artery access wrist positioning splint product assets of privately-held Accumed Systems Inc.
June 15, 2012
Technology
GE Healthcare introduced the latest addition to its Nuclear Medicine 600 series with a new performance SPECT/CT (single photon emission computed tomography/computed tomography) system, the Optima NM/CT 640.
June 15, 2012News
June 15, 2012 —Endosense, a pioneer and leader in force-sensing technology focused on improving the efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias, has announced enrollment completion in the TOCCASTAR clinical study.
June 15, 2012Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
June 15, 2012 — Stentys SA, a medical technology company commercializing the world's first and only self-apposing stent to treat acute myocardial infarction (AMI), announced that it has enrolled the first patient in its APPOSITION IV clinical study using its new self-apposing sirolimus-eluting stent.
June 15, 2012Technology
June 15, 2012 — Cardiosolutions Inc. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Dexterity Steerable Introducer, a next-generation structural heart access introducer and delivery conduit.
June 15, 2012News
June 15, 2012 — CardiAQ Valve Technologies (CardiAQ), which has developed the world’s first self-conforming and self-anchoring technology for nonsurgical transcatheter mitral valve implantation (TMVI), today announced that the company has achieved a cardiovascular medicine milestone: a bioprosthetic mitral heart valve was successfully implanted as a compassionate treatment into an 86-year-old male suffering from severe mitral regurgitation (MR 4+).
June 15, 2012Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
June 15, 2012 — At the Society of Nuclear Medicine’s (SNM) 59th Annual Meeting in Miami Beach, Fla., June 9-12, Cardinal Health introduced new technology enhancements that make it possible for hospital nuclear medicine departments and imaging centers to seamlessly improve data integration and the overall efficiency of their operations.
June 15, 2012
Technology
June 15, 2012 — To enable hospitals to keep pace with the latest technological advances and offer better patient care and improved workflow while containing costs, Toshiba America Medical Systems, Inc. announces the availability of VeloCT.
June 15, 2012
Technology
June 14, 2012 — Fujifilm Medical Systems USA Inc. announced the availability of Synapse Mobility 3.0, a new zero-footprint application with improved features that enable access to Fujifilm's suite of Synapse products, from handheld mobile devices to Macintosh- or Windows-based PCs.
June 14, 2012Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Feature
June 14, 2012 — A U.S. Food and Drug Administration (FDA) advisory panel voted in favor of recommending expanding the indication for the Edwards Lifesciences Sapien transcatheter heart valve for the treatment of high-risk patients. Currently, the Sapien is only indicated for patients who are too sick to undergo valve replacement surgery for severe, symptomatic aortic stenosis. The panel voted 11-0, with one abstention, that the benefits of the heart valve outweighed the risks for these patients.
June 14, 2012News
June 14, 2012 — Abiomed Inc. said today it received Health Canada approval to market the Impella cVAD (ventricular assist device), a new percutaneous Impella heart pump that provides peak flow of approximately 4 liters of blood per minute.
June 14, 2012
News
June 13, 2012 — Physicians presented at EuroPCR 2012 the results of two multicenter, randomized controlled trials, the BELLO and PACIFIER studies, each one showing statistically significant advantages of using an IN.PACT drug-eluting balloon from Medtronic Inc. over a corresponding conventional treatment for coronary and peripheral artery disease (CAD and PAD), respectively.
June 13, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now